Gongwin Biopharm Holdings Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 833,000 compared to TWD 248,000 a year ago. Operating loss was TWD 117.366 million compared to TWD 128.823 million a year ago. Net loss was TWD 93.072 million compared to TWD 109.824 million a year ago. Basic loss per share was TWD 0.89 compared to TWD 1.07 a year ago.